Page 4 - Q2 Results

Dish TV Q2 results: Net loss widens to ₹132.6 crore, revenue drops 26.4%

Direct-to-home firm Dish TV India Ltd on Friday reported a widening of its consolidated net loss to Rs 132.65 crore in the September quarter of FY26 on account of a rise in alternative entertainment options, inflationary pressures, and currency depreciation. The company had reported a net loss of Rs 37.38 crore in the July-September quarter a year ago, according to a regulatory filing from Dish TV. Its revenue from the operation slipped 27.41 per cent to Rs 291.13 crore in the September quarter. The same was Rs 395.62 crore in the corresponding quarter. Dish TV "EBITDA for 2Q FY26 stood at Rs 31.8 crore, a decrease of 77.9 per cent year-over-year," the company said in its earnings statement. "The decline in EBITDA was primarily due to the rise of alternative entertainment options, inflationary pressures, and currency depreciation. However, the company is confident that its new initiatives will begin to yield results in the coming quarters," it said. Total expenses of Dish TV were

Multiple growth triggers strengthen outlook for Samvardhana Motherson

Samvardhana Motherson delivered stronger-than-expected operating performance in Q2, prompting brokerages to raise estimates as higher content per vehicle

FirstCry parent reports ₹2,099 crore in revenue for September quarter

Brainbees Solutions, parent of children's retailer FirstCry, posts a 10% year-on-year revenue increase and reduces losses by 20% for the quarter ending September 2025

Glenmark Pharmaceuticals Q2 results: Profit jumps 72% to ₹610.43 cr

Glenmark Pharmaceuticals Ltd on Friday reported a 72.2 per cent jump in consolidated profit after tax at Rs 610.43 crore in the second quarter ended September 2025 on the back of its licensing deal with AbbVie for investigational asset 'ISB 2001'. The company had posted a consolidated profit after tax (PAT) of Rs 354.49 crore in the corresponding period last fiscal, Glenmark Pharmaceuticals Ltd said in a regulatory filing. Consolidated total revenue from operations was at Rs 6,046.87 crore as against Rs 3,433.8 crore in the same period a year ago, it added. Total expenses in the quarter under review were at Rs 3,894.98 crore as against Rs 3,000.64 crore in the same period last fiscal, the company said. "Q2FY26 reflects the steady progress we are making in strengthening Glenmark's scientific and strategic foundation. The AbbVie partnership for ISB 2001, along with the income recognised this quarter, is a significant validation of our scientific strength and enables us to advance the

Marico's Q2 net profit dips marginally even as revenue jumps 30.7%

Marico reported a slight dip in Q2FY26 net profit despite healthy revenue growth, steady India demand, and strong international business performance

OIL Q2 results: Profit dips 43% to ₹1,044 cr as crude realisations fall

The state-owned firm's standalone profit, which excludes earnings from joint ventures and overseas operations, fell to 10.44 billion rupees ($118.8 million)

Stock Market Highlights: Late buying lifts Sensex 84 pts, Nifty ends atop 25,900; PSU Banks shine

Stock market close highlights, November 14: Market sentiment also improved following the NDA's victory in the Bihar Election 2025.

DCB Bank zooms 37% in 1 month, trades at 5-year high; here's why

Shares of DCB Bank rallied 5% to ₹177.45 and were trading at its highest level since February 2020.

MRF Q2FY26 results: Net profit up 11.7% at ₹525.6 cr, dividend declared

MRF Q2FY26 results: Net profit up 11.7% at ₹525.6 cr, dividend declared

Marico Q2 results: Profit dips marginally to ₹432 cr, revenue rises 30.7%

Homegrown FMCG major Marico Ltd on Friday reported a marginal decline in consolidated net profit to Rs 432 crore for the September quarter of this fiscal, as gross margin contracted, on account of high base and inflation in key commodities. It had posted a net profit of Rs 433 crore in the July-September quarter a year ago, according to a regulatory filing by Marico. However, Marico's consolidated revenue from operations rose 30.7 per cent to Rs 3,482 crore in the September quarter of FY'26. It was at Rs 2,664 crore in the corresponding period a year ago. "In Q2FY26, revenue from operations was at Rs 3,482 crore, up 31 per cent year-on-year, with underlying volume growth of 7 per cent in the India business and constant currency growth of 20 per cent in the international business. "Consolidated and India revenue growth stood at multi-quarter highs," Marico said in its earnings statement. Total expenses of Marico increased 35.87 per cent in the September quarter to Rs 2,981 ...

Natco Pharma Q2 results: Consolidated net profit down 23.44% at ₹517.9 cr

Natco Pharma Ltd on Friday reported a 23.44 per cent decline in consolidated net profit at Rs 517.9 crore in the second quarter ended September 30, 2025, impacted by higher R&D expenses and one-time employee bonus. The company had posted a consolidated net profit of Rs 676.5 crore in the same quarter of the previous fiscal, Natco Pharma said in a regulatory filing. Consolidated revenue from operations in the second quarter stood at Rs 1,363 crore, as against Rs 1,371.1 crore in the corresponding period last fiscal, it added. Total expenses in the quarter under review stood at Rs 849.3 crore, as compared to Rs 616.7 crore in the same period a year ago, the company said. During the quarter, the company incurred substantial R&D expenses on bioequivalence and one-time employee bonuses, in addition to other business-related provisions, Natco Pharma said. Formulations export revenue was lower at Rs 1,147 crore in the second quarter, compared to Rs 1,211.3 crore in the year-ago ...

Defence index soars 5% in 1 week; what's driving Paras, Data Patterns?

At 01:40 PM on Friday; Nifty India Defence index was the top gainer among sectoral indices, up 0.85 per cent as compared to 0.43 per cent decline in the Nifty 50.

Oswal Pumps share price jumps 6% on strong Q2 results; key numbers inside

Oswal Pumps shares gained after the company posted a strong performance for the September quarter of FY26 (Q2FY26).

Ipca Labs jumps 7% after Q2 results; buy, sell or hold? Analysts suggest

Ipca Laboratories share price was trading 6.2 per cent higher at ₹1,382.60 compared to previous session's close of ₹1,302 on the NSE

Bharat Dynamics shares jump 7% after Q2 results; check outlook and target

Bharat Dynamics shares rose 7 per cent after it reported a jump in its profit in the second quarter of the current financial year

Sagility soars 7% as over 950 million equity shares change hands on NSE

According to reports, a promoter entity is likely to have sold up to 16.4% stake in Sagility via block deals, with a floor price of ₹46.4 per share.

Jubilant FoodWorks stock jumps 8% on Q2FY26 results; should you buy?

Jubilant FoodWorks share price jumped as much as 8.5 per cent on the BSE in the intraday trade on the back of solid Q2 results

Samvardhana Motherson rallies 4%, nears 52-wk high. Should you buy or hold?

Samvardhana Motherson management said the transformative measures the company has implemented are expected to maintain momentum and accelerate further in H2FY26.

Q2 results today: Tata Motors PV, Oil India, Marico among others on Nov 14

Q2FY26 company results: Firms including Exide Industries, MRF, Siemens, Glenmark Pharma, and Inox Wind are also to release their July-September earnings reports today

Stocks to Watch today: Muthoot Finance, TaMo CV, LG Electronics, Pine Labs

Stocks to Watch today: Muthoot Finance, Tata Motors CV, LG Electronics, Eicher Motors, Pine Labs, NBCC and Bharat Dynamics are among the stocks to watch today, November 14, 2025